Total CD3+ T-cells, as well as cytotoxic CD8+, helper CD4+, and regulatory FOXP3+ T-cells were evaluated in the stromal and intra-epithelial compartments in tumor samples before and after NACT. The gene discussed is CD8A; the disease is neoplasm.